Autoimmune islet destruction in spontaneous type 1 diabetes is not β-cell exclusive

被引:163
|
作者
Winer, S
Tsui, H
Lau, A
Song, AH
Li, XM
Cheung, RK
Sampson, A
Afifiyan, F
Elford, A
Jackowski, G
Becker, DJ
Santamaria, P
Ohashi, P
Dosch, HM
机构
[1] Hosp Sick Children, Res Inst, Toronto, ON M5G 1X8, Canada
[2] Univ Toronto, Dept Pediat, Toronto, ON, Canada
[3] Univ Toronto, Dept Immunol, Toronto, ON, Canada
[4] Syn X Pharma Inc, Toronto, ON, Canada
[5] UHN, Ontario Canc Inst, Dept Med Biophys, Toronto, ON, Canada
[6] UHN, Ontario Canc Inst, Dept Immunol, Toronto, ON, Canada
[7] Childrens Hosp, Dept Pediat, Pittsburgh, PA 15213 USA
[8] Univ Pittsburgh, Pittsburgh, PA USA
[9] Univ Calgary, Hlth Sci Ctr, Dept Microbiol & Infect Dis, Fac Med, Calgary, AB T2N 4N1, Canada
[10] Univ Calgary, Hlth Sci Ctr, Julia MacFarlane Diabet Res Ctr, Fac Med, Calgary, AB, Canada
关键词
D O I
10.1038/nm818
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Pancreatic islets of Langerhans are enveloped by peri-islet Schwann cells (pSC), which express glial fibrillary acidic protein (GFAP) and S100beta. SC-autoreactive T- and B-cell responses arise in 3- to 4-week- old diabetes-prone non-obese diabetic (NOD) mice, followed by progressive pSC destruction before detectable beta-cell death. Humans with probable prediabetes generate similar autoreactivities, and autoantibodies in islet-cell autoantibody (lCA)-positive sera co-localize to pSC. Moreover, GFAP-specific NOD T- cell lines transferred pathogenic peri-insulitis to NOD/severe combined immunodeficient (NOD/SCID) mice, and immunotherapy with GFAP or S100beta prevented diabetes. pSC survived in rat insulin promoter lymphocytic choriomeningitis virus (rip-LCMV) glycoprotein/CD8(+) T-cell receptor(9p) double-transgenic mice with virus-induced diabetes, suggesting that pSC death is not an obligate consequence of local inflammation and cell destruction. However, pSC were deleted in spontaneously diabetic NOD mice carrying the CD8(+) /8.3 T-cell receptor transgene, a T cell receptor commonly expressed in earliest islet infiltrates. Autoimmune targeting of pancreatic nervous system tissue elements seems to be an integral, early part of natural type 1 diabetes.
引用
收藏
页码:198 / 205
页数:8
相关论文
共 50 条
  • [1] Autoimmune islet destruction in spontaneous type 1 diabetes is not β-cell exclusive
    Shawn Winer
    Hubert Tsui
    Ambrose Lau
    Aihua Song
    Xiaomao Li
    Roy K. Cheung
    Anastazia Sampson
    Fatemeh Afifiyan
    Alisha Elford
    George Jackowski
    Dorothy J. Becker
    Pere Santamaria
    Pamela Ohashi
    H -Michael Dosch
    Nature Medicine, 2003, 9 : 198 - 205
  • [2] Islet regeneration needed for overcoming autoimmune destruction - considerations on the pathogenesis of type 1 diabetes
    von Herrath, M
    Homann, D
    PEDIATRIC DIABETES, 2004, 5 : 23 - 28
  • [3] Resistance of the target islet tissue to autoimmune destruction contributes to genetic susceptibility in Type 1 diabetes
    Natasha J Hill
    Aleksandr Stotland
    Michelle Solomon
    Patrick Secrest
    Elizabeth Getzoff
    Nora Sarvetnick
    Biology Direct, 2
  • [4] Macrophages in islet destruction in autoimmune diabetes mellitus
    Burkart, V
    Kolb, H
    IMMUNOBIOLOGY, 1996, 195 (4-5) : 601 - 613
  • [5] Islet-Expressed CXCL10 Promotes Autoimmune Destruction of Islet Isografts in Mice With Type 1 Diabetes
    Bender, Christine
    Christen, Selina
    Scholich, Klaus
    Bayer, Monika
    Pfeilschifter, Josef M.
    Hintermann, Edith
    Christen, Urs
    DIABETES, 2017, 66 (01) : 113 - 126
  • [6] T cell autoimmunity and type 1 diabetes: A model of progression toward islet cell destruction
    Becker, DJ
    Dosch, HM
    PEDIATRIC RESEARCH, 2000, 47 (04) : 124A - 124A
  • [7] Pathophysiological mechanisms involving aggressive islet cell destruction in fulminant type 1 diabetes
    Tanaka, Shoichiro
    Aida, Kaoru
    Nishida, Yoriko
    Kobayashi, Tetsuro
    ENDOCRINE JOURNAL, 2013, 60 (07) : 837 - 845
  • [8] Islet-immune interactions in type 1 diabetes: the nexus of beta cell destruction
    Peters, L.
    Posgai, A.
    Brusko, T. M.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2019, 198 (03): : 326 - 340
  • [9] Noninvasive diagnosis of recurrent autoimmune type 1 diabetes after islet cell transplantation
    Korutla, Laxminarayana
    Rickels, Michael R.
    Hu, Robert W.
    Freas, Andrew
    Reddy, Sanjana
    Habertheuer, Andreas
    Harmon, Joey
    Korutla, Varun
    Ram, Chirag
    Naji, Ali
    Vallabhajosyula, Prashanth
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 (06) : 1852 - 1858
  • [10] Peri-islet Schwann cell destruction is the initial pathogenic event in type 1 diabetes
    Winer, S
    Tsui, H
    Lau, A
    Song, AH
    Li, XM
    Cheung, RK
    Samson, A
    Jackowski, G
    Becker, DJ
    Dosch, M
    DIABETES, 2002, 51 : A5 - A5